| Filed | Form | Description | |
|---|---|---|---|
| 3/10/26 | PRE 14A | PRE 14A | → |
| 3/21/25 | DEFA14A | DEFA14A | → |
| 3/21/25 | DEF 14A | DEF 14A | → |
| 3/15/24 | DEFA14A | DEFA14A | → |
| 3/15/24 | DEF 14A | DEF 14A | → |
| 3/17/23 | DEFA14A | DEFA14A | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 3/9/26 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | → |
| 3/9/26 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | → |
| 3/9/26 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | → |
| 3/9/26 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | → |
| 3/9/26 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | → |
| 3/4/26 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | → |
| ↓ | |||
Lantheus, headquartered in Billerica, Massachusetts, is a company in the radiopharmaceuticals business. It has strategic partnerships with Bayer, Novartis, Regeneron as well as GE Healthcare and Siemens Healthineers.